2005 Newborn Screening and Genetic Testing Symposium.Oct. 24-27. The Hilton Portland and Executive Tower in Portland, OR, is the site of the 2005 Newborn Screening newborn screening Neonatology The analysis of a neonate's blood for metabolic or other disorders to prevent mental retardation, disability or death and Genetic Testing Symposium, sponsored by APHL APHL Association of Public Health Laboratories and the CDC See Control Data, century date change and Back Orifice. CDC - Control Data Corporation . This event is intended for laboratory professionals, counselors, and other personnel involved with newborn screening and genetics programs; maternal and child healthcare providers; public health laboratory directors; and other public health personnel. Focusing on newborn screening, genetic testing, and policy issues affecting public health entities at the state and national levels, the symposium will give special emphasis to lab technologies including tandem mass spectrometry Tandem mass spectrometry, also known as MS/MS, involves multiple steps of mass spectrometry selection, with some form of fragmentation occurring in between the stages. , DNA analysis, and new immunoassays. The conference program--which includes keynote, general, and poster sessions--is worth up to 16 P.A.C.E credits. A pre-conference session addressing quality assurance/control and follow-up, and a post-conference session on congenital adrenal hyperplasia Congenital Adrenal Hyperplasia Definition CAH is a genetic disorder characterized by a deficiency in the hormones cortisol and aldosterone and an over-production of the hormone androgen, which is present at birth and affects sexual development. are worth a combined total of 11.5 additional credit hours. Visit www.aphl.org for registration and event information. An early-bird registration fee is available until Sept. 23, 2005. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion